About
Ascilion is the world leader in sampling of dermal interstitial fluid (dISF). A pioneer within hollow microneedle technology since 2012, Ascilion has developed the only solution available for sampling of practical amounts of pure dISF, enabling complete quantitative biomarker evaluation. Ascilion's product PELSA is painless, quick, easy to use and leaves no residual mark on the skin. PELSA is available for research use and for pharmaceutical or cosmetic testing applications.
Technologies
Outlook
Microsoft Office 365
Amazon AWS
WordPress.org
Mobile Friendly
Google Tag Manager
Reviews
Keywords
pharmaceuticals
biomarker research
b2b
healthcare equipment & supplies
regulatory compliance
biomarker detection
biomarker detection in skin
diagnostics
diagnostic microneedles
biomarker analysis
medical equipment and supplies manufacturing
biomarker biomarkers
immunology research
biomarker profiling in skin
dermal interstitial fluid biomarkers
silicon microneedles
mems fabrication
hollow microneedles
medical device development
chronic urticaria sampling
services
biotechnology
biomolecule extraction from skin
clinical trials
medical devices
digital health
silicon chip
medical technology
ex vivo skin models
micro-electro-mechanical systems
Company Information
-
Employees 11
-
Founded 2012
-
Total Funding $2229990
Location
22 Isafjordsgatan, Stockholm, Stockholm County, Sweden, 164 40
